Nani,
Thanks for detailed considerations above. In short, excellent and thanks.
From where I am sitting this is falling beautifully into our hands. Several reasons:
1. It seems to be considered a medical stock and not an insurer. Initially it was priced somewhere in between . If rated as medical then 21 to 24 times may be the go. As crazy as it is.
2. Maximum profit would be BUPA and if it gets there then MPL profit will be $340 m. If this is valued at 24 times then you get a price approximating $3 . What a joke.
3. It looks as though overseas instos are interested and they may well price this which is fantastic .
4. I remember T 1 when it listed many years ago. It's the only time I remember the government raising the price range just like MPL. And Telstra went off at the top of the revised range and still listed at a nice premium.
5. In short, all the long shots are coming home to roost and this can only auger well for listing.
6. For retail at $2, I can see a stag of around 30 percent.
